Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Bioavailability, tissue distribution and excretion studies of a potential anti-osteoporotic agent, medicarpin, in female rats using validated LC-MS/MS method.

Taneja I, Raghuvanshi A, Rama Raju KS, Awasthi P, Rashid M, Singh S, Goel A, Singh SP, Wahajuddin M.

J Pharm Biomed Anal. 2019 Nov 18;180:112978. doi: 10.1016/j.jpba.2019.112978. [Epub ahead of print]

PMID:
31855725
2.

Publisher Correction: Combining Biomarkers with EMR Data to Identify Patients in Different Phases of Sepsis.

Taneja I, Reddy B, Damhorst G, Zhao SD, Hassan U, Price Z, Jensen T, Ghonge T, Patel M, Wachspress S, Winter J, Rappleye M, Smith G, Healey R, Ajmal M, Khan M, Patel J, Rawal H, Sarwar R, Soni S, Anwaruddin S, Davis B, Kumar J, White K, Bashir R, Zhu R.

Sci Rep. 2019 Nov 19;9(1):17419. doi: 10.1038/s41598-019-53691-4.

3.

LC-ESI-MS/MS method for the simultaneous determination of isoformononetin, daidzein, and equol in rat plasma: Application to a preclinical pharmacokinetic study.

Raju KSR, Rashid M, Gundeti M, Taneja I, Malik MY, Singh SK, Chaturvedi S, Challagundla M, Singh SP, Gayen JR, Wahajuddin M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Oct 15;1129:121776. doi: 10.1016/j.jchromb.2019.121776. Epub 2019 Aug 28.

PMID:
31629309
4.

Social Determinants of Child Marriage in Rural India.

Seth R, Bose V, Qaiyum Y, Chandrashekhar R, Kansal S, Taneja I, Seth T.

Ochsner J. 2018 Winter;18(4):390-394. doi: 10.31486/toj.18.0104.

5.

Development and validation of UPLC-MS/MS assay for quantification of cladrin: Absolute bioavailability and dose proportionality study in rats.

Rashid M, Singh SK, Malik MY, Jahan S, Chaturvedi S, Taneja I, Raju KS, Naseem Z, Gayen JR, Wahajuddin M.

J Pharm Biomed Anal. 2018 Apr 15;152:289-297. doi: 10.1016/j.jpba.2018.01.044. Epub 2018 Jan 31.

PMID:
29454264
6.

Species differences between rat and human in vitro metabolite profile, in vivo predicted clearance, CYP450 inhibition and CYP450 isoforms that metabolize benzanthrone: Implications in risk assessment.

Taneja I, Karsauliya K, Rashid M, Sonkar AK, Rama Raju KS, Singh SK, Das M, Wahajuddin M, Singh SP.

Food Chem Toxicol. 2018 Jan;111:94-101. doi: 10.1016/j.fct.2017.11.009. Epub 2017 Nov 7.

PMID:
29126801
7.

Combining Biomarkers with EMR Data to Identify Patients in Different Phases of Sepsis.

Taneja I, Reddy B, Damhorst G, Dave Zhao S, Hassan U, Price Z, Jensen T, Ghonge T, Patel M, Wachspress S, Winter J, Rappleye M, Smith G, Healey R, Ajmal M, Khan M, Patel J, Rawal H, Sarwar R, Soni S, Anwaruddin S, Davis B, Kumar J, White K, Bashir R, Zhu R.

Sci Rep. 2017 Sep 7;7(1):10800. doi: 10.1038/s41598-017-09766-1. Erratum in: Sci Rep. 2019 Nov 19;9(1):17419.

8.

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification.

Hassan U, Ghonge T, Reddy B Jr, Patel M, Rappleye M, Taneja I, Tanna A, Healey R, Manusry N, Price Z, Jensen T, Berger J, Hasnain A, Flaugher E, Liu S, Davis B, Kumar J, White K, Bashir R.

Nat Commun. 2017 Jul 3;8:15949. doi: 10.1038/ncomms15949.

9.

RP-HPLC Separation of Isomeric Withanolides: Method Development, Validation and Application to In situ Rat Permeability Determination.

Yaseen Malik M, Taneja I, Raju KSR, Rahaman Gayen J, Singh SP, Sangwand NS, Wahajuddin M.

J Chromatogr Sci. 2017 Aug 1;55(7):729-735. doi: 10.1093/chromsci/bmx027. Review.

PMID:
28407087
10.

Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with Miltefosine.

Anand D, Yadav PK, Patel OP, Parmar N, Maurya RK, Vishwakarma P, Raju KS, Taneja I, Wahajuddin M, Kar S, Yadav PP.

J Med Chem. 2017 Feb 9;60(3):1041-1059. doi: 10.1021/acs.jmedchem.6b01447. Epub 2017 Jan 20.

PMID:
28059524
11.

Bioanalysis of antitubercular drugs using liquid chromatography.

Raju KSR, Gundeti M, Malik MY, Kadian N, Rashid M, Taneja I, Singh SP, Wahajuddin M.

J Pharm Biomed Anal. 2017 Feb 5;134:295-309. doi: 10.1016/j.jpba.2016.11.006. Epub 2016 Nov 9. Review.

PMID:
27951471
12.

Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry.

Kadian N, Raju KS, Rashid M, Malik MY, Taneja I, Wahajuddin M.

J Pharm Biomed Anal. 2016 Jul 15;126:83-97. doi: 10.1016/j.jpba.2016.03.052. Epub 2016 Mar 25. Review.

PMID:
27179186
13.

Naturally Occurring Carbazole Alkaloids from Murraya koenigii as Potential Antidiabetic Agents.

Patel OP, Mishra A, Maurya R, Saini D, Pandey J, Taneja I, Raju KS, Kanojiya S, Shukla SK, Srivastava MN, Wahajuddin M, Tamrakar AK, Srivastava AK, Yadav PP.

J Nat Prod. 2016 May 27;79(5):1276-84. doi: 10.1021/acs.jnatprod.5b00883. Epub 2016 May 3.

PMID:
27136692
14.

DBS-platform for biomonitoring and toxicokinetics of toxicants: proof of concept using LC-MS/MS analysis of fipronil and its metabolites in blood.

Raju KS, Taneja I, Rashid M, Sonkar AK, Wahajuddin M, Singh SP.

Sci Rep. 2016 Mar 10;6:22447. doi: 10.1038/srep22447.

15.

Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats.

Pal S, Khan K, China SP, Mittal M, Porwal K, Shrivastava R, Taneja I, Hossain Z, Mandalapu D, Gayen JR, Wahajuddin M, Sharma VL, Trivedi AK, Sanyal S, Bhadauria S, Godbole MM, Gupta SK, Chattopadhyay N.

Toxicol Appl Pharmacol. 2016 Mar 15;295:12-25. doi: 10.1016/j.taap.2016.02.002. Epub 2016 Feb 3.

PMID:
26851681
16.
18.

Dietary Isoflavones as Modulators of Drug Metabolizing Enzymes and Transporters: Effect on Prescription Medicines.

Taneja I, Raju KS, Wahajuddin M.

Crit Rev Food Sci Nutr. 2016 Jul 29;56 Suppl 1:S95-S109. doi: 10.1080/10408398.2015.1045968. Review.

PMID:
26561312
19.

No effect on pharmacokinetics of tamoxifen and 4-hydroxytamoxifen by multiple doses of red clover capsule in rats.

Raju KS, Taneja I, Valicherla GR, Challagundla MK, Rashid M, Syed AA, Gayen JR, Singh SP, Wahajuddin M.

Sci Rep. 2015 Nov 4;5:16126. doi: 10.1038/srep16126.

20.

In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data.

Arora S, Taneja I, Challagundla M, Raju KS, Singh SP, Wahajuddin M.

Toxicol Lett. 2015 Nov 19;239(1):1-8. doi: 10.1016/j.toxlet.2015.08.202. Epub 2015 Aug 13.

PMID:
26278343
21.

Prevalence and Severity of Symptoms in a Sample of African Americans and White Participants.

Taneja I, So S, Stewart JM, Evans M, Jason LA.

J Cult Divers. 2015 Summer;22(2):50-8.

22.

LC-ESI-MS/MS method for bioanalytical determination of osteogenic phytoalexin, medicarpin, and its application to preliminary pharmacokinetic studies in rats.

Taneja I, Raju KS, Challagundla M, Raghuvanshi A, Goel A, Wahajuddin M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 15;1001:9-16. doi: 10.1016/j.jchromb.2015.06.025. Epub 2015 Jul 9.

PMID:
26241182
23.

Development and validation of an LC-MS/MS method for simultaneous determination of piperaquine and 97-63, the active metabolite of CDRI 97-78, in rat plasma and its application in interaction study.

Wahajuddin M, Singh SP, Taneja I, Raju KS, Gayen JR, Siddiqui HH, Singh SK.

Drug Test Anal. 2016 Feb;8(2):221-7. doi: 10.1002/dta.1807. Epub 2015 May 14.

PMID:
25975936
24.

Simultaneous determination of centchroman and tamoxifen along with their metabolites in rat plasma using LC-MS/MS.

Rama Raju KS, Taneja I, Singh SP, Tripathi A, Mishra DP, Hussain KM, Gayen JR, Singh SK, Wahajuddin M.

Bioanalysis. 2015;7(8):967-79. doi: 10.4155/bio.14.253.

PMID:
25966009
25.

Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97-78 in rat plasma using the HPLC-ESI-MS/MS method: application to drug interaction study.

Wahajuddin M, Singh SP, Taneja I, Raju KS, Gayen JR, Siddiqui HH, Singh SK.

Malar J. 2015 Apr 22;14:172. doi: 10.1186/s12936-015-0684-5.

26.

Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: an approach by enhanced bioavailability.

Dwivedi P, Khatik R, Chaturvedi P, Khandelwal K, Taneja I, Raju KS, Dwivedi H, Singh SK, Gupta PK, Shukla P, Tripathi P, Singh S, Tripathi R, Wahajuddin, Paliwal SK, Dwivedi AK, Mishra PR.

Colloids Surf B Biointerfaces. 2015 Feb 1;126:467-75. doi: 10.1016/j.colsurfb.2014.12.052. Epub 2015 Jan 7.

PMID:
25616971
27.

Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats.

Dwivedi P, Khatik R, Khandelwal K, Taneja I, Raju KS, Wahajuddin, Paliwal SK, Dwivedi AK, Mishra PR.

Int J Pharm. 2014 May 15;466(1-2):321-7. doi: 10.1016/j.ijpharm.2014.03.036. Epub 2014 Mar 20.

PMID:
24657144
28.

Investigation of the functional role of P-glycoprotein in limiting the oral bioavailability of lumefantrine.

Wahajuddin, Raju KS, Singh SP, Taneja I.

Antimicrob Agents Chemother. 2014;58(1):489-94. doi: 10.1128/AAC.01382-13. Epub 2013 Nov 4.

29.

Dried blood spots in bioanalysis of antimalarials: relevance and challenges in quantitative assessment of antimalarial drugs.

Taneja I, Erukala M, Raju KS, Singh SP, Wahajuddin.

Bioanalysis. 2013 Sep;5(17):2171-86. doi: 10.4155/bio.13.180. Review.

PMID:
23962252
30.

Utility of noninvasive biomatrices in pharmacokinetic studies.

Raju KS, Taneja I, Singh SP, Wahajuddin.

Biomed Chromatogr. 2013 Oct;27(10):1354-66. doi: 10.1002/bmc.2996. Epub 2013 Aug 13. Review.

PMID:
23939915
31.

Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes.

Maurya R, Soni A, Anand D, Ravi M, Raju KS, Taneja I, Naikade NK, Puri SK, Wahajuddin, Kanojiya S, Yadav PP.

ACS Med Chem Lett. 2012 Dec 11;4(2):165-9. doi: 10.1021/ml300188t. eCollection 2013 Feb 14.

32.

Disposition of pharmacologically active dietary isoflavones in biological systems.

Wahajuddin, Taneja I, Arora S, Raju KS, Siddiqui N.

Curr Drug Metab. 2013 May;14(4):369-80. Review.

PMID:
23330931
33.

Baroreceptor unloading in postural tachycardia syndrome augments peripheral chemoreceptor sensitivity and decreases central chemoreceptor sensitivity.

Taneja I, Medow MS, Clarke DA, Ocon AJ, Stewart JM.

Am J Physiol Heart Circ Physiol. 2011 Jul;301(1):H173-9. doi: 10.1152/ajpheart.01211.2010. Epub 2011 May 2.

34.

Ventilatory baroreflex sensitivity in humans is not modulated by chemoreflex activation.

Stewart JM, Rivera E, Clarke DA, Baugham IL, Ocon AJ, Taneja I, Terilli C, Medow MS.

Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1492-500. doi: 10.1152/ajpheart.01217.2010. Epub 2011 Feb 11.

35.

Respiration drives phase synchronization between blood pressure and RR interval following loss of cardiovagal baroreflex during vasovagal syncope.

Ocon AJ, Medow MS, Taneja I, Stewart JM.

Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H527-40. doi: 10.1152/ajpheart.00257.2010. Epub 2010 Nov 12.

36.

Initial orthostatic hypotension in the young is attenuated by static handgrip.

Clarke DA, Medow MS, Taneja I, Ocon AJ, Stewart JM.

J Pediatr. 2010 Jun;156(6):1019-1022.e1. doi: 10.1016/j.jpeds.2010.01.035. Epub 2010 Mar 28.

37.

Postural change alters autonomic responses to breath-holding.

Taneja I, Medow MS, Clarke DA, Ocon AJ, Stewart JM.

Clin Auton Res. 2010 Apr;20(2):65-72. doi: 10.1007/s10286-009-0046-x. Epub 2009 Dec 11.

38.

Peripheral vascular adaptation and orthostatic tolerance in Fontan physiology.

Krishnan US, Taneja I, Gewitz M, Young R, Stewart J.

Circulation. 2009 Nov 3;120(18):1775-83. doi: 10.1161/CIRCULATIONAHA.109.854331. Epub 2009 Oct 19.

39.

Increased phase synchronization and decreased cerebral autoregulation during fainting in the young.

Ocon AJ, Kulesa J, Clarke D, Taneja I, Medow MS, Stewart JM.

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2084-95. doi: 10.1152/ajpheart.00705.2009. Epub 2009 Oct 9.

40.

Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome.

Ocon AJ, Medow MS, Taneja I, Clarke D, Stewart JM.

Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H664-73. doi: 10.1152/ajpheart.00138.2009. Epub 2009 Jun 5.

41.

Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome.

Stewart JM, Ocon AJ, Clarke D, Taneja I, Medow MS.

Hypertension. 2009 May;53(5):767-74. doi: 10.1161/HYPERTENSIONAHA.108.127357. Epub 2009 Mar 16.

42.

Multiresolution wavelet analysis of time-dependent physiological responses in syncopal youths.

Nowak JA, Ocon A, Taneja I, Medow MS, Stewart JM.

Am J Physiol Heart Circ Physiol. 2009 Jan;296(1):H171-9. doi: 10.1152/ajpheart.00963.2008. Epub 2008 Nov 7.

43.

Increased vasoconstriction predisposes to hyperpnea and postural faint.

Taneja I, Medow MS, Glover JL, Raghunath NK, Stewart JM.

Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H372-81. doi: 10.1152/ajpheart.00101.2008. Epub 2008 May 23.

44.

Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response.

Stewart JM, Taneja I, Raghunath N, Clarke D, Medow MS.

Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H327-34. doi: 10.1152/ajpheart.00126.2008. Epub 2008 May 9.

45.

Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.

Stewart JM, Taneja I, Glover J, Medow MS.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H466-73. Epub 2007 Nov 9.

46.

Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome.

Stewart JM, Medow MS, Minson CT, Taneja I.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2161-7. Epub 2007 Jul 27.

47.
48.

Reduced central blood volume and cardiac output and increased vascular resistance during static handgrip exercise in postural tachycardia syndrome.

Stewart JM, Taneja I, Medow MS.

Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1908-17. Epub 2007 Jul 6.

49.
50.

Cyclooxygenase and nitric oxide synthase dependence of cutaneous reactive hyperemia in humans.

Medow MS, Taneja I, Stewart JM.

Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H425-32. Epub 2007 Mar 16.

Supplemental Content

Loading ...
Support Center